Dr. Bissan Ahmed

Dr

Dr. Bissan Ahmed


Experience


*Date and place of birth: 05/6/69, Damascus, Syria.

*Nationality: Belgian.

*Diploma in Medical Science (1996). Damascus University, Syria.

*Training in Damascus hospital (1996-1997), Syria.

*Master of Medical Sciences-Pathology (1999), Division Pathology, Univ Hosp, KULeuven University, Belgium (promotor: Prof. J. Van den Oord).

*September 1999 pre-doctorate research at the Lab. Exp Radiobiology, Division Radiotherapy/Oncology, Univ Hosp, KULeuven University, Belgium.

*Doctorate in Medical Science (2006), Lab. Exp Radiobiology and Oncology, KULeuven University, Belgium. (Promotor: Prof. P. Lambin) (Co-promotor: Prof. A. Griffioen).

*Post doc. Position in Harvard University, Lab. of Prof. Judah Folkman, Vascular Biology Program, U.S.A (2006).

* Research Fellow in the pathology department, Liege University, Belgium (2008).

*Research Associate in Portland University (U.S.A) (2010).

*Clinical Research Associate in ULB University (Belgium) (Jules Bordet Institute) ( 2012).

* Prof. of Pathology and Histology and Cancer Researcher in Pharmacology department in the Arab international University in Damascus Syria (2019)
Awards:

Award (oral presentation) at the Belgian Association for Cancer Research (BACR) annual meeting, Brussels, 01/2002.

ERR-2001 travel Award based on the quality of the scientific work presented in 31st Annual Meeting of the European Society for Radiation Biology, 09/2001, Dresden, Germany.

Belgian American Educational Foundation Honorary Award (2006).

Grants:

CLAYTON FOUNDATION FOR RESEARCH yearly grant in Portland University 2010.

Patents

Fc- Endostatin in Harvard University.

STY-RMR in Portland University.

Publications:
Ahmed B, van den Oord JJ: Expression of neuronal isoform of nitric oxide synthase (nNOS) and its inhibitor, protein inhibitor of nNOS, in pigment cell lesions of the skin. Br J Dermatol 141, 12-19, 1999.(IF: 2.67).

Ahmed B, van den Oord JJ: Expression of the inducible isoform of nitric oxide synthase (iNOS) in pigment cell lesions of the skin. Br J Dermatol 142, 432-440, 2000. (IF: 2.67).

Landuyt W, Ahmed B, Nuyts S, Theys J, Op de Beeck M, Rijnders A, Anne J, van Oosterom A, Van den Bogaert W, Lambin.P: In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment. Int J Radiat Oncol Biol Phys 49, 443-450, 2001. (IF: 3).
Ahmed B, van Eijk LI, Bouma-ter Steege JC, van der Schaft DW, van Esch AM, Joosten-Achjanie SR, Lambin Ph, Landuyt W, Griffioen AW. A defined role of angiogenesis inhibition in the vascular targeting activity of combretastatin A-4 phosphate. Int J Cancer 105, 20-25, 2003.(IF: 4.4).

Chen B, Ahmed B, Landuyt W, Ni Y, Gaspar R, Roskams T, de Witte P. Potentiation of photodynamic therapy with hypericin by mitomycine C in the RIF-1 mouse tumor model. Photochem Photobiol 78, 278-282, 2003. (IF: 2).


Wildiers H , Ahmed B , Guetens G , De Boeck G , De Bruijn E , Landuyt W, Van Oosterom A.
Unexpected interactions between Nicotinamideand CPT-11 in a rhabdomyosarcoma tumor model. Anticancer Res 23, 4055-4059, 2003.(IF:1.39).

Kamuhabwa A , Agostinis P , Ahmed B , Landuyt W , Van Cleynenbreugel B, Van Poppel H , de Witte P. Hypericin as a potential phototherapeutic tool in superficial transitional cell carcinoma bladder cancer. Photochem Photobiol Sci 3,772-780, 2004. (IF: 2)


Wildiers H , Ahmed B , Guetens G , De Boeck G , De Bruijn E , Landuyt W, van Oosterom A
A.Combretastatin A-4 phosphate enhances CPT-11 activity independently of
administration sequence. Eur J Cancer 40, 284-290, 2004. (IF: 3.3).

Thoeny HC, De Keyzer F, Chen F, Vandecaveye V, Verbeken EK, Ahmed B, Sun X, Ni Y, Bosmans H, Hermans R, van Oosterom A, Marchal G, Landuyt W. Diffusion-weighted magnetic resonance imaging allows non-invasive in vivo monitoring of the effects of combretastatin A-4 phosphate after repeated administration. Neoplasia 7(8):779-87, 2005. (IF: 3.8).

Ahmed B, Landuyt W, Griffioen AW, van Oosterom A, Van den Bogaert W, Lambin P. In Vivo antitumor effect of combretastatin A-4 phosphate added to fractionated irradiation. Anticancer Res. 26(1A), 307-10, 2006. (IF: 1.4).
Tong-Young Lee, Robert M. Tjin Tham Sjin, Shahla Movahedi, Ahmed B, Elke A. Pravda, Kin-Ming Lo, Stephen D. Gillies, Judah Folkman, and Kashi Javaherian. Linking Antibody FC Domain to Endostatin Significantly Improves Endostatin Half- Life and Efficacy. Clin Cancer Res 2008 14: 1487-1493. (IF: 6.4).

T.J. McFarland, D.J.Bond, Ahmed B, H.A Llias, Y.Pan, J.T.Stout, B.Appukuttan. Isoforms of human RTEF-1 can differently modulate the expression of VEGF within choroidal endothelial cells (CECs). ( Manuscript in preparation).

Ahmed B,T.J. McFarland, D.J.Bond, H.A Llias, Y.Pan, J.T.Stout, B.Appukuttan.The therapeutic potential of RTEF-1 in Cancer (Manuscript in preparation).

P. Bourgeois, Ahmed B. Differential expression of the Na+/I− symporter by endocrine receptor status: a potential new therapeutic target in estrogen receptor negative high grade breast cancers (Manuscript in preparation).

P. Bourgeois, Ahmed B. Implications of a Simplified Dosimetric Approach After 131I Administration for the Management of Differentiated Thyroid Carcinomas (Manscript in preparation).

P. Bourgeois, Ahmed B and B. Vanderlinden. A Nuclear Medicine Approach To Treat Evolutive Metastatic Or Locally Advanced Radio-Iodine Resistant “Differentiated” Thyroid Carcinomas (DTC) Using 13-Cis Retinoic Acids: Report Of 8 Cases (Manscript in preperation).

Bissan Ahmed, Paul Debbage, Sergej Skvortsov, Peter Lukas and Ira Skvortsova. Head and Neck Squamous Cell Carcinoma (HNSCC) Protein Profiles Associated with Tumor Response to Treatmentjournal of translational protemics 2015 2: 3.14

Antoine Digonnet, MD, Sophie vankerckhove, Michel Moreau, MD, Esther Willemse, MD, Marie Quiriny1, Bissan Ahmed, MD, PHD, Nicolas de Saint Aubain,MD, Guy Andry, MD, Pierre Bourgeois, MD, PHD. Near infrared fluorescent imaging, after intravenous injection of indocyanin green, during neck dissection in head and neck cancer patients (A feasibility study Head Neck. 2016 Apr;38 Suppl 1:E1833-7. doi: 10.1002/hed.24331. Epub 2015 Dec 24.
Gabriel Liberale, MD, Sophie Vankerckhove, Maria Gomez Caldon, MD, Bissan Ahmed, PhD, Michel Moreau, MD, Issam El Nakadi, MD, Denis Larsimont, PhD 9 (3), Vincent Donckier, PhD (1), Pierre Bourgeois, PhD. Fluorescence Imaging After Indocyanine Green Injection for Detection of Peritoneal Metastases in Patients Undergoing Cytoreductive Surgery for Peritoneal Carcinomatosis From Colorectal Cancer: A Pilot Study. CANCER. (published in Annals of Surgery journal 05. 01.

Bissan Ahmed, Andrew Stempel, Trevor J. McFarland, Bruce Ksander, Binoy Appukuttan and Tim Stout. Inhibition of Ocular Tumor and Endothelial Cell Growth with a TEAD4216 Peptide Fragment. World Journal of Oncology Research, 2018, 5, 1-9.

 

 

 


Education

- Diploma in Medical Science (1996). Damascus University, Syria.

- Training in Damascus hospital (1996-1997), Syria.

- Master of Medical Sciences-Pathology (1999), Division Pathology, Univ